FDA eMDR System Enhancements 2026: A Guide for Medical Device Manufacturers

On July 20, 2026, the US FDA announced major enhancements to the electronic Medical Device Reporting (eMDR) system, impacting all manufacturers required to submit adverse event reports. This episode provides a practical guide to understanding the new structured data requirements, enhanced validation rules, and updated submission APIs. We cover the mandatory compliance deadline of January 1, 2027, and outline actionable steps for regulatory and quality teams to update SOPs, train staff, and ensure system compatibility for a seamless transition. Key Questions: - What specific changes did the FDA announce for the eMDR system on July 20, 2026? - How will these enhancements impact the submission process for adverse event reports? - Which new data fields, such as for UDI, are being introduced and why are they important? - What is the mandatory compliance deadline for transitioning to the updated system? - How should manufacturers update their internal SOPs and quality systems? - What steps are necessary to ensure third-party reporting software remains compatible? - Who within a medical device company needs to be aware of these changes? - What are the potential benefits of the new eMDR system for post-market surveillance? Sources: - https://www.fda.gov/medical-devices/news-events-medical-devices/cdrh-new-news-and-updates How Pure Global can help: Pure Global helps MedTech and IVD companies navigate complex regulatory changes and achieve faster global market access. Our experts can assist your team in adapting to new requirements like the FDA's eMDR enhancements by developing updated regulatory strategies and managing post-market surveillance obligations. We act as your local representative in over 30 markets, using advanced AI and data tools to streamline technical dossier preparation and submissions. Whether you're a startup or a multinational, we provide end-to-end support to ensure your products remain compliant. Contact us at [email protected] or visit https://pureglobal.com to learn more. Explore our free AI regulatory tools and product database at https://pureglobal.ai.